| Literature DB >> 31704277 |
Maria E Sheean1, Eva Malikova2, Dinah Duarte3, Giuseppe Capovilla4, Laura Fregonese5, Matthias P Hofer5, Armando Magrelli6, Segundo Mariz5, Fernando Mendez-Hermida7, Robert Nistico8, Tim Leest9, Nikolaos V Sipsas10, Stelios Tsigkos5, Dinko Vitezic11, Kristina Larsson5, Bruno Sepodes12, Violeta Stoyanova-Beninska13.
Abstract
This review provides an overview of nonclinical in vivo models that can be used to support orphan designation in selected rare infectious diseases in Europe, with the aim to inform and stimulate the planning of nonclinical development in this area of often neglected diseases.Entities:
Mesh:
Year: 2019 PMID: 31704277 DOI: 10.1016/j.drudis.2019.10.015
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851